Group 1 - Lowprazole
Group 1 - Lowprazole
Group 1 - Lowprazole
VISION MISSION
Ranking Providing
in top 10 pharma companies in high quality product, carrying
2023 in Egypt ,throw delivering innovative solution that rich
innovative pharmaceutical
product to pharmaceutical field
field inEgypt
Company profile
SWOT ANALYSIS
4 distributors (UCP, Pharma overseas, ensure the availability of our goods
Ibn Sina and Egydrug). 20 mg and vials are required to
complete theportfolio
34 medical rep can increase share of
voice
as a new technique with ortho
doctors . opportunities
Affordable price 7 sachets 20 l.e.
Huge market with20 % 2016 growth
then 26 %growth and 21 %growth per
2018.
threats PPIs & H2 antagonists are indicated
other generics are registering the same in 118different indication from 10
combination. different specialities
Most of brands aren’t focusing in
Alexandria andUE
TOW S A N A LY S I S
•SPECIALITY
MAIN prescribers are :
IM GP PULMONARY ORTHO
LOWPRAZOLE RX
LOWPRAZOLE
RX FOR REGION
Segmentation Basis
PHYSICIAN PHYSICIAN PATIENT BELIEVES
LOCATION BACKGROUND SPECIALITY POPULATION TREATMENT
gp specialist
all egypt IM Class A +30 ppi trend
KOLs GP Class B 10 to fast and
University stuff
ORTHO 30
consultant in
NEURO/PSYCh long day
governmental
hospitals
protection
HYPRIDE
BELIVES
UPDATES BELIVES PRICE
SEGMENT A SEGMENT B
Positioning
lowprazole 40 mg and sachet form
unique form 1st in egyptian market
fast and rapid relief with full day protection
high conc from sodium bicarbonates
trendy .
Positioninig
CUSTOMER
PREORIGINATION
reflux PHARMACY
BUYING
(hyperacidity )
JOURNEY
ORIGINATION
CLINIC
DIAGNOSIS
clinical symptoms
TREATMENT
CHOICE & ultrasound
PPI NEWTREND
BRAND CHOICE
COMPLIANCE
Leverage point andbehavioral
objectives
Brand choice
Fulfillment
RX FILLED RX SWITCHED OTC
pharmacist 70 % 5% 25 %
WITH 10 %MARKET SHARE FROM TOTAL MARKET & 9%FROM PPI MARKET
3 years plan
KPIs and Control
SALES TEAM FOLLOW UP
SALES REPORT & ACHIVEMENT
IMS FOLLOW UP
VISITS& CALL RATE & KEY MASSAGE DELIVERING
RTD & GROUP MEETING REPORTS 3 \MANTH
ATTENDANCE CUSTOMERS
MARKETING TEAM ATTENDACE FOR EVALUATION & FEEDBACK
PHARMACY ACTIVITIES FOLLOWUP
PHARMACY COMPAIGIN & SALES TEAM
PHARMACY SALES
SALES TEAM REPORT & ORDER FOLLOW UP
STANDLONE REPORTS
ATTENDANCE CUSTOMERS
DIRECT FEEDBACK FROM ATTENDACE (REGULAR EVALUATION SURVEYS )
FOLLOW UP WITH FIELD VISITFROM MARKETING TEAM WITHIN3 MANTHES AFTER
IMS ANALYSIS
facebook.com/repsology
repsology.org
youtube.com/c/repsology
linkedin.com/company/repsology
telegram.me/repsologyofficial
Business platform for
twitter.com/repsology the pharmaceutical
Industry staff.
instagram.com/repsology